← Leaderboards
Nassima Ait-Daoud
University Of Texas Hlth Sci Ctr San Ant
$5,876,216
Attributed
$11,176,034
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,176,034 · 5
By mechanism
R01$9,148,430 · 3
UG3$1,197,126 · 1
K23$830,478 · 1
Top collaborators
- Bankole A Johnson6 shared
- Robert M Anthenelli5 shared
- Paul Michael Cinciripini5 shared
- Ming D Li4 shared
- David Alan Gorelick2 shared
- Wynn Legon2 shared
- Eric Weintraub1 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Bankole A Johnson$31,821,485
Others in their field
Top investigators on “Craving”
- Rajita Sinha · Yale University$32,214,060
- Barbara J Mason · Scripps Research Institute, The$21,503,310
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$21,234,516
- Kathleen Theresa Brady · Medical University Of South Carolina$20,546,089
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$20,264,889
- Andrew S Huhn · Johns Hopkins University$19,514,484
Research focus
CravingBehavioralPharmaceutical PreparationsSerotoninDouble-Blind MethodPsychosocialMediatingRandomizedQuality Of LifePlacebosAbstinencePatient Self-ReportRelapseMedicinePharmacotherapyTherapeutic EffectNeuronsMissionResponseSerotonin TransporterDopamineOndansetronGenotypeResearch Personnel
Grant awards (22)
Low-intensity focused ultrasound for cocaine use disorder: High resolution targeting of the human insula$594,806
UG3 · FY2023 · DA · contact PI
Low-intensity focused ultrasound for cocaine use disorder: High resolution targeting of the human insula$602,320
UG3 · FY2022 · DA · contact PI
1/2-Pharmacogenetic Treatments for Alcoholism$531,569
R01 · FY2016 · AA
1/2-Pharmacogenetic Treatments for Alcoholism$515,621
R01 · FY2015 · AA
New Pharmacotherapy for Alcohol and Co-morbid Disorders$827,356
R01 · FY2014 · AA · contact PI
1/2-Pharmacogenetic Treatments for Alcoholism$531,569
R01 · FY2014 · AA
New Pharmacotherapy for Alcohol and Co-morbid Disorders$806,997
R01 · FY2013 · AA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$882,510
R01 · FY2012 · AA · contact PI
1/2-Pharmacogenetic Treatments for Alcoholism$543,690
R01 · FY2012 · AA
New Medication Treatments for Stimulant Dependence$270,117
R01 · FY2012 · DA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$900,625
R01 · FY2011 · AA · contact PI
New Medication Treatments for Stimulant Dependence$585,021
R01 · FY2011 · DA · contact PI
New Pharmacotherapy for Alcohol and Co-morbid Disorders$964,231
R01 · FY2010 · AA · contact PI
New Medication Treatments for Stimulant Dependence$593,698
R01 · FY2010 · DA · contact PI
New Medication Treatments for Stimulant Dependence$589,753
R01 · FY2009 · DA · contact PI
New Medication Treatments for Stimulant Dependence$605,673
R01 · FY2007 · DA · contact PI
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$172,710
K23 · FY2005 · AA
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$152,477
K23 · FY2004 · AA
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$16,285
K23 · FY2004 · AA
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$164,929
K23 · FY2003 · AA
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$161,207
K23 · FY2002 · AA
DO GENES &BRAIN ACTIVITY PREDICT ALCOHOL RISK?$162,870
K23 · FY2001 · AA